Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06336486
Status:
COMPLETED
Last Update Posted:
2024-04-01
First Post:
2024-03-19
Brief Title:
the Effectiveness of Intermittent Pneumatic Compression on Neuropathic Pain in Patients With Diabetic Polyneuropathy
Sponsor:
Busra Gunes
Organization:
Balikesir University
Study Overview
Official Title:
Comparison of the Effectiveness of Pregabalin Therapy on Neuropathic Pain in Patients With Diabetic Polyneuropathy and the Treatments Applied in Patients Receiving Pregabalin and Intermittent Pneumatic Compression Therapy
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this studythe effectiveness of intermittent pneumatic compression therapy on neuropathic pain and quality of life in patients with neuropathic pain due to type 2 diabetes was investigated
Detailed Description:
The investigators conducted our research from 50 patients with type 2 diabetes of 5-20 years who received pregabalin treatment with diabetic neuropathy with consent form between 40-75 yearsThe investigators divided the patients into two equal groups some of the patients were given an intermittent pneumatic compression program at a pressure of 35 mmhg for 30 min to the lower extremity for 10 days of extreme alternation in our clinic and pregabalin treatment was continuedonly pregabalin treatment of the other group was continued VAS PQAS LANSS SF-36 were evaluatedThe evaluation was done before the treatment at the end of the intermittent pneumatic compression treatmentapproximately 2 weeks after the start of the treatment and 3 months later
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None